Patent holdings for IPC class C07D 333/72

Total number of patents in this class: 85

10-year publication summary

4
4
5
7
5
4
4
7
5
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Zhejiang Jingxin Pharmaceutical Co., Ltd.
22
5
BASF SE
21098
4
Merck Patent GmbH
5752
3
Ambrx, Inc.
175
3
Shanghai Jingxin Biomedical Co., Ltd.
16
3
Syngenta Participations AG
1730
2
Duke University
3125
2
Purdue Research Foundation
3732
2
Chugai Seiyaku Kabushiki Kaisha
1379
2
Kyushu University, National University Corporation
1669
2
Nippon Kayaku Kabushiki Kaisha
1451
2
Shangyu Jingxin Pharmaceutical Co., Ltd.
8
2
Ryvu Therapeutics SA
44
2
Shanghai Jingxin Biology & Pharmaceutical Co., Ltd.
7
2
Glaxo Group Limited
4145
1
Novartis AG
10612
1
Samsung Electronics Co., Ltd.
149198
1
LG Chem, Ltd.
17706
1
The Regents of the University of California
20303
1
Janssen Pharmaceutica N.V.
3358
1
Other owners 43